Crossover Health

Belkins
Crossover Health is driving the next-generation, employer-led health care movement, fundamentally changing the way care is practiced, delivered, and experienced. We partner with health activist employers who understand the value of growing their human capital, delivering a solution that meets their biggest obstacles – cost, access and engagement. Within our Primary Care Platform, our health centers serve as the hub to seamlessly integrate behavioral health, physical medicine, health coaching, as well as care navigation services, delivering an unrivaled patient experience. Utilizing our membership and tech-enabled model, employees are engaging in their health with unprecedented outcomes— we not only lower your total spend, but deliver unmatched NPS, Engagement and Patient Satisfaction scores allowing you to nurture your most important asset – your human capital.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BUSINESS INSIGHTS

COEUS HOLDINGS ANNOUNCES PARTNERSHIP WITH INSIGHT CONSULTING GROUP (ICG) TO ADDRESS THE HEALTHCARE INDUSTRY’S CHANGING RESEARCH AND INSIGHT LANDSCAPE

September 18, 2021

news image

COEUS Holdings, LLC, and its subsidiaries, together a leading boutique life sciences technology and consulting firm, today announced that it has entered a partnership with Insight Consulting Group (ICG). The partnership seeks to bridge the gaps between payers, healthcare providers, and consumers by developing insights and strategies that are reflective of today’s integrated needs. The partnership will produce and apply comprehensive insights to inform strategy that could advance access to ...

Read More

BUSINESS INSIGHTS

ASYMCHEM AND LANOVA MEDICINES ENTER INTO PARTNERSHIP AGREEMENT, EXPANDING BIOLOGICAL CAPABILITIES

September 17, 2021

news image

Asymchem today announced a strategic partnership agreement to provide LaNova Medicines with one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration. The collaboration between Asymchem and LaNova will include small molecule drugs, monoclonal antibodies, double antibodies, ADC projects and potentially other R&D and production initiatives. This partnership will take full advantage of Asymchem's recently co...

Read More

BUSINESS INSIGHTS

CEM CORPORATION AND AMBIOPHARM ENTER INTO US PARTNERSHIP FOR GMP PEPTIDE PRODUCTION

September 16, 2021

news image

CEM Corporation and AmbioPharm, Inc. are pleased to announce the formation of a partnership to produce GMP peptides for the global market. The partnership includes the exclusive 1Use of CEM's microwave peptide synthesis technology on a large scale for the production of GMP peptides up to several kilograms using its own scalable reactors. The main advantages of this new relationship are the extremely short production times, the ability to efficiently produce more difficult peptide sequences, ...

Read More

BUSINESS INSIGHTS

September 18, 2021

news image

COEUS HOLDINGS ANNOUNCES PARTNERSHIP WITH INSIGHT CONSULTING GROUP (ICG) TO ADDRESS THE HEALTHCARE INDUSTRY’S CHANGING RESEARCH AND INSIGHT LANDSCAPE

COEUS Holdings, LLC, and its subsidiaries, together a leading boutique life sciences technology and consulting firm, today announced that it has entered a partnership with Insight Consulting Group (ICG). The partnership seeks to bridge the gaps between payers, healthcare providers, and consumers by developing insights and strategies that are reflective of today’s integrated needs. The partnership will produce and apply comprehensive insights to inform strategy that could advance access to ...

Read More

BUSINESS INSIGHTS

September 17, 2021

news image

ASYMCHEM AND LANOVA MEDICINES ENTER INTO PARTNERSHIP AGREEMENT, EXPANDING BIOLOGICAL CAPABILITIES

Asymchem today announced a strategic partnership agreement to provide LaNova Medicines with one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration. The collaboration between Asymchem and LaNova will include small molecule drugs, monoclonal antibodies, double antibodies, ADC projects and potentially other R&D and production initiatives. This partnership will take full advantage of Asymchem's recently co...

Read More

BUSINESS INSIGHTS

September 16, 2021

news image

CEM CORPORATION AND AMBIOPHARM ENTER INTO US PARTNERSHIP FOR GMP PEPTIDE PRODUCTION

CEM Corporation and AmbioPharm, Inc. are pleased to announce the formation of a partnership to produce GMP peptides for the global market. The partnership includes the exclusive 1Use of CEM's microwave peptide synthesis technology on a large scale for the production of GMP peptides up to several kilograms using its own scalable reactors. The main advantages of this new relationship are the extremely short production times, the ability to efficiently produce more difficult peptide sequences, ...

Read More